Tissue repair research
BPC-157 Research review
A closer look at a tendon-healing experiment and the gap between animal findings and human recovery claims.
Animal studySources checked September 12, 2026
01 / Context first
The research setting
Rats with surgically injured Achilles tendons, with accompanying laboratory experiments.
02 / The findings
What the sources found
- The selected experiment reported improved tendon-healing measures in treated rats.
03 / The open questions
Where the evidence stops
- This experiment does not establish effectiveness for a person's sports injury.
- It does not determine human dosing or long-term safety.
04 / Safety context
Before drawing conclusions
FDA identifies limited human safety information and potential immune-response and impurity concerns for compounded BPC-157.
These reviews do not provide instructions for self-treatment. Discuss personal medical questions with a qualified clinician.
05 / Go to the originals
Read the sources
Inspect the original research and regulatory context behind this review.
- Original research — PubMed abstractGastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. ↗
- FDA safety informationCertain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks ↗
Sources checked September 12, 2026. Next editorial review due December 11, 2026.
Read the review methodology →